| Financier | Commitments |
|---|---|
| IDA Grant | 55.15 |
Chad COVID-19 Strategic Preparedness and Response Project
Abstract*
While the project will help strengthen the national capacity to respond to the COVID-19 emergency, the distribution of equipment and supplies and the training of staff will prioritize the seven provinces identified by the WHO as high-risk provinces. These provinces are those were there are points of entry to the country and include: N’Djamena, Lake Chad, Mayo Kebbi East, Mayo Kebbi West, Logone Oriental, Moyen-Chari and Ouaddai.
The project has 4... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Chad.
Key Details
Project Details
P173894
Closed
Kofi Amponsah
Republic of Chad
April 10, 2020
(as of board presentation)
April 24, 2020
April 30, 2020
US$ 55.15 million
Ministère de la Santé Publique
2020
US$ 55.15 million
N/A
Substantial
June 30, 2024
TBD
BANK APPROVED
April 2, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 55.15 |
| IBRD + IDA Commitment | 55.15 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 55.15 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 5, 2024 | IDA-D9150 | Loan Disb | -1,309,160.00 |
| Feb 13, 2024 | IDA-D9150 | Loan Disb | -1,239,848.00 |
| Apr 30, 2024 | IDA-D9150 | Loan Disb | 1,236,739.00 |
| Apr 9, 2024 | IDA-D9150 | Loan Disb | 2,817,836.00 |
| Jun 16, 2023 | IDA-D6270 | Loan Disb | -1,604,799.00 |
| May 19, 2023 | IDA-D9150 | Loan Disb | 241,388.73 |
| Jun 16, 2023 | IDA-D6270 | Loan Disb | -5,388.55 |
| Jun 2, 2023 | IDA-D9150 | Loan Disb | 51,726.28 |
| Jun 23, 2023 | IDA-D9150 | Loan Disb | 335,789.88 |
| Aug 21, 2023 | IDA-D9150 | Loan Disb | 429,059.70 |
| Aug 8, 2023 | IDA-D9150 | Loan Disb | 319,703.94 |
| Jun 20, 2023 | IDA-D6270 | Loan Disb | -2,068.57 |
| Jun 20, 2023 | IDA-D9150 | Loan Disb | 879,573.56 |
| Sep 18, 2023 | IDA-D9150 | Loan Disb | 5,778,345.00 |
| May 11, 2023 | IDA-D9150 | Loan Disb | 295,649.62 |
| Mar 1, 2023 | IDA-D9150 | Loan Disb | 78,925.19 |
| Mar 1, 2023 | IDA-D9150 | Loan Disb | 0.05 |
| Apr 25, 2023 | IDA-D9150 | Loan Disb | 168,475.38 |
| Mar 24, 2023 | IDA-D9150 | Loan Disb | 825,763.80 |
| Mar 28, 2023 | IDA-D9150 | Loan Disb | 401,093.50 |
| Oct 7, 2022 | IDA-D6270 | Loan Disb | 329,194.10 |
| Oct 3, 2022 | IDA-D6270 | Loan Disb | 304,556.50 |
| Sep 8, 2021 | IDA-D6270 | Loan Disb | 89,259.10 |
| Oct 5, 2021 | IDA-D6270 | Loan Disb | 16,738.93 |
| Oct 22, 2021 | IDA-D6270 | Loan Disb | 72,981.04 |
| Jul 20, 2021 | IDA-D6270 | Loan Disb | 6,760.22 |
| Jul 20, 2021 | IDA-D6270 | Loan Disb | 137,510.12 |
| Dec 3, 2021 | IDA-D6270 | Loan Disb | 87,792.61 |
| Oct 26, 2021 | IDA-D6270 | Loan Disb | 212,992.55 |
| Nov 19, 2020 | IDA-D6270 | Loan Disb | 457,600.00 |
| Apr 15, 2021 | IDA-D6270 | Loan Disb | 104,671.49 |
| Jul 19, 2021 | IDA-D6270 | Loan Disb | 252,692.44 |
| Nov 24, 2020 | IDA-D6270 | Loan Disb | 98,874.62 |
| Feb 11, 2021 | IDA-D6270 | Loan Disb | 697,108.75 |
| Jan 11, 2021 | IDA-D6270 | Loan Disb | 45,093.68 |
| Dec 21, 2020 | IDA-D6270 | Loan Disb | 456,792.00 |
| Nov 30, 2020 | IDA-D6270 | Loan Disb | 58,397.78 |
| Mar 19, 2021 | IDA-D6270 | Loan Disb | 1,048.84 |
| Aug 14, 2020 | IDA-D6270 | Loan Disb | 703,500.00 |
| Mar 1, 2021 | IDA-D6270 | Loan Disb | 20,539.64 |
| Dec 7, 2020 | IDA-D6270 | Loan Disb | 942,043.50 |
| Dec 16, 2020 | IDA-D6270 | Loan Disb | 218,544.06 |
| Feb 19, 2021 | IDA-D6270 | Loan Disb | 39,666.40 |
| Jun 5, 2020 | IDA-D6270 | Loan Disb | 195,768.00 |
| Sep 28, 2020 | IDA-D6270 | Loan Disb | 40,745.69 |
| May 19, 2020 | IDA-D6270 | Loan Disb | 831,393.44 |
| Nov 13, 2020 | IDA-D6270 | Loan Disb | 98,874.62 |
| Oct 21, 2020 | IDA-D6270 | Loan Disb | 76,985.51 |
| Aug 10, 2020 | IDA-D6270 | Loan Disb | 8,022,509.00 |
| Oct 18, 2022 | IDA-D9150 | Loan Disb | 473,550.60 |
| Jan 20, 2022 | IDA-D9150 | Loan Disb | 870,170.56 |
| Aug 26, 2022 | IDA-D9150 | Loan Disb | 3,410,577.00 |
| Feb 9, 2022 | IDA-D9150 | Loan Disb | 453,600.00 |
| Jul 28, 2022 | IDA-D6270 | Loan Disb | 191,116.23 |
| Aug 29, 2022 | IDA-D6270 | Loan Disb | 135,487.80 |
| Feb 15, 2022 | IDA-D6270 | Loan Disb | -14,272.78 |
| Apr 7, 2022 | IDA-D6270 | Loan Disb | 18,560.09 |
| Jun 3, 2022 | IDA-D6270 | Loan Disb | 14,026.57 |
| Feb 24, 2022 | IDA-D6270 | Loan Disb | 5,370.73 |
| Jun 30, 2022 | IDA-D9150 | Loan Disb | 807,623.94 |
| Jun 30, 2022 | IDA-D6270 | Loan Disb | 709,705.94 |
| Jul 15, 2022 | IDA-D6270 | Loan Disb | 11,167.28 |
| May 27, 2022 | IDA-D9150 | Loan Disb | 3,238,434.00 |
| Apr 21, 2022 | IDA-D6270 | Loan Disb | 31,164.86 |
| Jul 12, 2022 | IDA-D6270 | Loan Disb | 28,603.91 |
| Jun 9, 2022 | IDA-D9150 | Loan Disb | 11,999,988.00 |
| Jun 24, 2022 | IDA-D6270 | Loan Disb | 545,751.25 |
| Mar 8, 2022 | IDA-D6270 | Loan Disb | 123,712.70 |
| Nov 17, 2021 | IDA-D6270 | Loan Disb | 149,231.20 |
| Apr 24, 2020 | IDA-D6270 | Loan Commitment | 16,950,000.00 |
| Sep 28, 2021 | IDA-D9150 | Loan Commitment | 38,200,000.00 |
| May 16, 2024 | IDA-D9150 | Loan Disb | 2,810,744.00 |
| Mar 25, 2024 | IDA-D9150 | Loan Disb | 138,691.60 |
| Apr 18, 2024 | IDA-D9150 | Loan Disb | -2,785,532.20 |
| Mar 11, 2024 | IDA-D9150 | Loan Disb | 1,293,443.40 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Satisfactory | 2024-10-04 |
| Procurement | Moderately Satisfactory | 2024-10-04 |
| Project Management | Satisfactory | 2024-10-04 |
| Progress towards achievement of PDO | Satisfactory | 2024-10-04 |
| Financial Management | Satisfactory | 2024-10-04 |
| Monitoring and Evaluation | Satisfactory | 2024-10-04 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Designated laboratories with COVID-19 functioning diagnostic equipment, test kits, and reagents per MPHNS guidelines Value 1.00 24.00 5.00 Date March 26, 2020 November 13, 2023 June 30, 2024 Comment Targeted healthcare facilities providing COVID-19 treatment with isolation capacity Value 0.00 100.00 100.00 Date March 26, 2020 July 31, 2022 June 30, 2024 Comment Suspected cases of COVID-19 cases reported and investigated based on national guidelines Value 9.00 212811.00 5000.00 Date April 8, 2020 November 13, 2023 June 30, 2024 Comment Laboratory confirmed cases of COVID-19 treated per approved protocol Value 3.00 7396.00 3000.00 Date March 26, 2020 November 13, 2023 June 30, 2024 Comment Population vaccinated, which is included in the priority population targets defined in national plan, female Value 0.00 51.07 50.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
3.1. Technical crisis coordination meetings issuing an official report on epidemic surveillance and response Value 0.00 64.00 52.00 Date March 26, 2020 November 13, 2023 June 30, 2024 Comment 2.1. Communication campaigns about COVID-19 broadcasted to communities Value 0.00 10.00 7.00 Date March 11, 2020 November 13, 2023 June 30, 2024 Comment 1.1. Update of National COVID-19 Response Action Plan Value No Yes Yes Date March 11, 2020 November 13, 2023 June 30, 2024 Comment 2.2. National COVID-19 risk communication and community engagement strategy established Value No Yes Yes Date March 11, 2020 July 31, 2022 June 30, 2024 Comment 1.2. Healthcare workers trained on surveillance and investigation Value 0.00 210.00 80.00 Date March 11, 2020 November 13, 2023 June 30, 2024 Comment 2.3. Key gender-sensitive messages and materials developed for public communications and advocacy, in alignment with demand plan Value No Yes Yes Date September 2, 2021 July 31, 2022 June 30, 2024 Comment 1.3. Health workers trained on case definition, management, infection prevention and control for COVID-19 Value 0.00 1514.00 2000.00 Date March 26, 2020 November 13, 2023 June 30, 2024 Comment 3.2. Establishment of monitoring and evaluation system for COVID-19 Value No Yes Yes Date March 26, 2020 July 31, 2022 June 30, 2024 Comment 2.4. Women community platforms delivering messages to promote women’s access to COVID-19 vaccines Value 0.00 128.00 100.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 1.4. Eligible households provided with food and basic supplies within quarantined populations Value 0.00 2450.00 2000.00 Date March 26, 2020 June 30, 2023 June 30, 2024 Comment 3.3. Complaints received and addressed through the Grievance Redress Mechanism (GRM) Value 0.00 2.00 100.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 2.5. Risk communication capacities developed through cascade training and/or mentorship at the subnational level Value No No Yes Date March 30, 2023 November 13, 2023 June 30, 2024 Comment 1.5. Eligible vaccine doses procured Value 0.00 2158956.00 800000.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 2.6. Community platforms supported and carrying out awareness-raising activities on health emergencies Value 0.00 0.00 40.00 Date May 17, 2023 May 17, 2023 June 30, 2024 Comment 1.6. Health staff trained in COVID-19 vaccination deployment per MPHNS-approved protocols, female Value 0.00 58.00 50.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 3.4. Effective Vaccine Management assessments implemented by a third party (e.g. an NGO) with composite scores of 80 percent or higher Value 0.00 80.00 50.00 Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 1.7. SOPs or guidelines established for collection and disposal of medical waste developed and shared with relevant stakeholders Value No Yes Yes Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 2.7. A strategy and plan in place for dis-and misinformation Value No No Yes Date March 30, 2023 March 30, 2023 June 30, 2024 Comment 1.8. Guidelines, documented procedures and/or tools for planning and conducting vaccine pharmacovigilance activities are established and available Value No Yes Yes Date September 2, 2021 November 13, 2023 June 30, 2024 Comment 2.8. Community leaders involved Value 0.00 0.00 100.00 Date March 30, 2023 November 13, 2023 June 30, 2024 Comment 1.9. Interoperable and interconnected real-time electronic notification system exist Value No No Yes Date March 30, 2023 March 30, 2023 June 30, 2024 Comment 1.10. RRTs established, trained, and equipped Value 24.00 24.00 34.00 Date May 17, 2023 March 30, 2023 June 30, 2024 Comment 1.11. Software to link surveillance electronic tools with the laboratory information management system at all levels Value No No Yes Date March 30, 2023 March 30, 2023 June 30, 2024 Comment 1.12. Drones’ technical specifications prepared Value No No Yes Date March 30, 2023 March 30, 2023 June 30, 2024 Comment 1.13. Drones’ environmental and social management plan (ESMP) prepared Value No No Yes Date March 30, 2023 March 30, 2023 June 30, 2024 Comment 1.14. Drones’ standard operating procedure prepared Value No No Yes Date May 17, 2023 May 17, 2023 June 30, 2024 Comment